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Systematic reviewEndocrine disrupting chemicals (EDC) are released into environment from different sources. They are mainly
used in packaging industries, pesticides and food constituents. Clinical evidence, experimental models, and epi-
demiological studies suggest that EDC have major risks for human by targeting different organs and systems in
the body.Multiplemechanisms are involved in targeting the normal system, through estrogen receptors, nuclear
receptors and steroidal receptors activation. In this review, differentmethods bywhich xenobiotics stimulate sig-
naling pathways and genetic mutation or DNA methylation have been discussed. These methods help to under-
stand the results of xenobiotic action on the endocrine system. Endocrine disturbances in the human body result
in breast cancer, ovarian problems, thyroid eruptions, testicular carcinoma, Alzheimer disease, schizophrenia,
nerve damage and obesity. EDC characterize a wide class of compounds such as organochlorinated pesticides,
industrial wastes, plastics and plasticizers, fuels and numerous other elements that exist in the environment or
are in high use during daily life. The interactions and mechanism of toxicity in relation to human general health
problems, especially endocrine disturbances with particular reference to reproductive problems, diabetes, and
breast, testicular and ovarian cancers should bedeeply investigated. There should also be a focus onpublic aware-
ness of these EDC risks and their use in routine life. Therefore, the aim of this review is to summarize all evidence
regarding different physiological disruptions in the body and possible involvedmechanisms, to prove the associ-
ation between endocrine disruptions and human diseases.
© 2015 Elsevier Inc. All rights reserved.1. Introduction
Endocrine system is a group of various glands that secrete hormones
to control metabolism, growth and development in tissue, sexual and
reproductive functions as well as sleep, and mood among other physio-
logical changes. The use of synthetic chemicals by human has been in-
creased extensively since the introduction of these chemicals.
Endocrine-disrupting chemicals (EDC) are structurally diverse class of
synthetic and natural compounds that possess the ability to alter vari-
ous mechanisms of the endocrine system and potentially induce ad-
verse health effects in exposed individuals and populations [1].
According to the latest report, about 800 chemicals that are being
used in daily life possess endocrine disrupting properties [2]. Out of
available EDC, only some of them have been examined. These chemicals
are involved in many chronic diseases like cardiovascular problems, di-armaceutical Sciences Research
7614411, Iran.
, Mohammad@TUMS.Ac.Irabetes, obesity, reproductive abnormalities, thyroid problems, neo-
plasm and many homeostatic imbalances [3].
2. Search strategy
Data was obtained from different scientiﬁc databases such as
PubMed, Google Scholar, ClinicalTrials.gov and ToxNet. The search
terms were “various types of EDC” “endocrine disrupting chemicals
and health effects”, “reproductive system and EDC”, “thyroid system
and endocrine disruption”, “EDC and cardiac system”, “nuclear recep-
tors and mechanism of EDC”, “EDC and oxidative stress”, “nervous sys-
tem and endocrine toxicants”, and “carcinogenicity and danger of
EDC”. The reference studies of animalmodelswere also analyzed for fur-
ther research and their applicability for studying different effects related
to environment, food and occupational settings exposed to EDC. Effects
of EDC in relation to different system, organs and sources of exposure
have been explained in Table 1. Table shows different epidemiological
studies conducted in different time periods with speciﬁc protocols and
different doses of EDC. Full understanding of this review article will
give us new direction to the future and guidance in endocrinology relat-
ed toxicology.
Table 1
List of studies whose results show association of EDC exposure and incidence of health effects.
Reference Model
Source of exposure
Type of EDC Duration of
exposure
Concentration Target system/organ
studied
Results
Ikezuki et al. [24] Epidemiologic Food packaging and diet (BPA) 15–18 weeks
gestation
1–2 ng/mL Ovarian ﬂuids Fetus damage
Gore [19] Experimental Pesticides and
environment
Methoxychlor or chlorpyrifos Acute 24 h Methoxychlor (0, 1, 10, 100) μM,
chlorpyrifos (0, 1, 10, 100) μM
Cell culture Alteration in gonadotropin
releasing hormone
Weidner et al. [21] Epidemiologic (male) Diet (vegetables, fruits) Pesticides Chronic Testes Cryptorchidism and
Hypospadias↑
Staessen et al. [20] Epidemiologic Environmental and
occupational
VOCs, PCBs and PAHs Chronic Reproductive DNA damage and urinary
dysfunctions
Hunt et al. [23] Experimental (female) Food packaging and diet BPA 6–8 days 100 and 360 ng/mL Reproductive Mammalian oocytes failure
and aneuploidy
Kelce et al. [124] Experimental Pesticides DDE 4 days 100 mg/kg and 200 mg/kg Reproductive Testosterone ↑
Alexander et al. [31] Epidemiologic
(case control study
mother–infants)
Environmental and
occupational
Alcohol, benzene, cigarette and
insecticides
Chronic Leukemia Leukemia in infants ↑
Cooper et al. [34] Experimental (female rats) Occupational Atrazine 21 days
chronic
50–300 mg/kg Ovary LH and Prolactin ↓
Wolff et al. [125] Epidemiologic (cohort study
female)
Environmental and
occupational
PCB and DDE Chronic Breasts cancer Breast cancer ↑
Schantz et al. [43] Experimental Environmental and
occupational
PCBs 1 month 32 mg/kg, 16 mg/kg, 64 mg/kg,
8 mg/kg
Thyroid system Hyper or hypo thyroid
activity ↑
Hurley [47] Experimental Environmental and
occupational
240 pesticides Chronic Thyroid system 10% ↑ thyroid follicle cell
tumors and 12% ↑ thyroid
tumors
McKinney et al. [49] Experimental Environmental and
occupational
(PCB) Acute Thyroid hormones and
liver
Thyroid hormones and
nuclear receptors are
targeted.
Darnerud et al. [50] Experimental Environmental 3,3′, 4,4′-tetrachlorobiphenyl
(CB-77)
Chronic 1 mg/kg and 10 mg/kg Thyroid hormones TT4 and Ft4 ↓
Braverman et al. [126] Epidemiologic Occupational Perchlorate, thiocyanate, and
nitrate
Chronic Thyroid system 4-h thyroid RAIU by 38% ↓
Hinton et al. [54] Experimental Food packaging and diet Phathalic acid Chronic Thyroid system Level of thyroid hormones
↓
Rousset [57] Experimental Food packaging and diet Methylparaben 2.0 × 10−4 M Thyroid system Nonstimulated and TSH- or
dibutyryl cyclic
AMP-stimulated cells
produced.
Lee et al. [67] Epidemiologic Environmental POPs Chronic Diabetes Prevalence of diabetes ↑
Alonso-Magdalena et al.
[69]
Experimental (pregnant
mice)
Food packaging and diet BPA Chronic 10 or 100 μg/kg/day Diabetes Insulin resistance ↑
Alonoso-Magdalena et al.
[127]
Experimental Contraceptive pills 17 beta estradiol Chronic 10 μg/kg Diabetes Hyperinsulinemia ↑
Lind and Lind [75] Epidemiologic Food packaging and diet BPA and phthalates Chronic Cardiovascular system Atherosclerosis ↑
Kaneda and Ohmori [84] Epidemiological
(male schizophrenia
patients)
Contraceptive pills Estradiol Chronic Nervous system Negative signs in male
schizophrenia patients ↑
Ali et al. [98] Experimental Aquatic/sea food Methyl mercury Acute 5–40 μM
1–5 mg/kg
Nervous system Oxidative strees in
hippocampus ↑
BPA: bisphenol A; PCBs: polychlorinated biphenyls; DDE: dichlorodiphenyldichloroethylene; PAHs: polyaromatic hydrocarbons; DNA: deoxyribonucleic acid; VOCs: volatile organic compounds; POPs: persistent organic pollutants; TSH: thyroid stim-
ulating hormone; AMP: adenosine monophosphate; TT4: tetra-iodo thyronine (thyroxin); Ft4: free T4 hormones; LH: luteinizing hormone; ↑: increase; ↓: decrease.
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The EDC are divided into major classes of chemicals containing var-
ious types of pesticides, industrial chemicals, plastic packaging compo-
nents, fuels and other materials that are used in daily life [4,5]. The
International Program on Chemical Safety (IPCS) suggests that “EDC
are such exogenous substances that altermany endocrine and hormon-
al functions in the body, resulting in various abnormalities”. Generally it
can be said that EDC are substances entering into the body that affects
synthesis, metabolism and excretion of hormones involved in homeo-
stasis, and developmental processes [2]. It has been reported that
from 120 indoor air and dust chemicals, 89 organic chemicals have
been identiﬁed as EDC; most abundant of these are phthalates (plasti-
cizers), o-phenyl phenols, 4-nonylphenols, and 4-tert-butylphenols
[6]. Phthalates have been reported as one of the major components of
food packaging materials which penetrate into the foods after leaching
through packaging bags [7]. Phthalates used as polymer materials in
shampoo bottles, and plastic food packaging pose high risk for human
health, by targeting endocrine system [8]. Pesticides are involved in var-
ious chronic diseases like cancers, diabetes, neurodegenerative disor-
ders, Parkinson, Alzheimer, amyotrophic lateral sclerosis (ALS), birthFig. 1. Routes of EDC release to the environment and their toxic effects ondefects, and reproductive disorders [9,10]. The most abundant of
phthalates are permethrins, and some banned pesticides like hepta-
chlor, DDT (dichlorodiphenyltrichloroethane), and methoxychlor.
These phthalates have been evidenced to cause indoor degradation of
different organs in humans [6]. Even some studies support that some
natural food components of animals and humans like phytoestrogens
e.g. apigenin and naringenin can also behave as EDC [11,12]. In this
study, damage and mechanisms involved for different organs and sys-
tems have been explained thoroughly and their impact on human
health, as well as detailed understanding of different physiological sys-
tems is stated in Fig. 1.
4. Organ and systemic effects of EDC
4.1. Reproductive and developmental effects
EDC damage normal physiological reactions related to the reproduc-
tive system. In relation to this a number of in vitro and in vivo evidence
are available about testicular and ovarian abnormalities [13]. EDC
reduce number as well as quality of sperms, along with an increase in
occurrence of testicular, prostate and breast cancer [14]. To a greathuman health from the viewpoint of biological systems and organs.
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and for all these, environmental pollutants have been reported to play
a key role [15]. Testicular dysgenesis syndrome (TDS), poor semenqual-
ity, and testicular carcinoma are main illnesses known to be associated
with some environmental pollutants affecting the endocrine system
[16]. Similarly, very low sperm count due to toxicity of environmental
pollutants has been reported [17,18]. In the female reproductive sys-
tem, diethylstilbestrol (DES) induces somemorphological and function-
al changes [15]. In an in vitro study two organochlorine pesticides,
methoxychlor and chlorpyrifos have caused alteration in the biosynthe-
sis of gonadotropin hormone in hypothalamic GT1-7 cells [19]. So, tox-
icants target thewhole systemof hormone release in humans. In a study
conducted in Belgium on 120 girls of the general population,
polychlorinated biphenyls (PCBs) caused damage to developmental
stages of the reproductive system [20]. There are also evidence of repro-
ductive malfunctioning in children of pesticides exposed workers [21].
BPA (Bisphenol-A), commonly exposed EDC, leaches out from plastic
packaging materials like reusable baby bottles, water carboys and
other household materials. So, BPA also puts children at high danger
of ED problems [22].
Accidental exposure of mice to BPA from cage andwater plastic bot-
tles causes differentmeiotic disturbances and aneuploidy in the oocytes
[23,24]. Similarly miscarriages observed in woman are mostly because
of aneuploidy [25]. Sugiura-Ogasawara et al., [26] observed that the
risk of miscarriage was high in women exposed to BPA.
4.2. Carcinogenicity
After the Second World War, a large number of chemicals used as
weapons have been analyzed for endocrine disrupting properties in
the human body [27]. An analysis in animal studies has been conducted
on about 48 EDC listed under CDC (center for disease control and pre-
vention in the US), and the results have shown close linkage tomutage-
nicity, developmental effects and carcinogenicity [28]. A mathematical
computerized based simulation study on animals showed that many
endocrine disrupting chemicals have devastating effects like mutage-
nicity, thyroid gland cancer, prostate cancer and much more related to
metabolic diseases and cardiovascular problems [29]. Natural or syn-
thetic estrogens can also serve as carcinogenic and most cases of such
tumors and toxicities develop during developmental stages of different
organs. Maternal source proved to bemain route of such toxicities [30].
A study on infants and children living in agricultural areas using house-
hold pesticides has proved an increased rate of leukemia and lymphoma
[31]. Tobacco smoke, containing different constituents like alkenes, ni-
trosamines, aromatic and heterocyclic compounds is the main cause of
lung and alveolar cancer. In addition, carbamates cause leukemia in off-
spring [32].
Similarly, atrazine is an extensively used pesticide for controlling the
population of weeds in crops [33]. The atrazine exposure is associated
with cancer of the mammary glands [34]. The American Cancer Society
reported that prostate cancer cases are increasing rapidly [35]. Benign
prostate hyperplasia is the major problem of prostate cancer observed
in 50% of the men at age of 60 [36]. During the last ﬁfty years,
xenoesterogens have been assumed as the most probable cause for de-
veloping breast cancer [37]. It was studied that increased estrogen level
during pregnancy causes breast cancer and other endocrine disruptions
[2,38]. Toxaphene, DDT and other pesticides with endocrine disrupting
properties have been proved to induce breast tumor.
4.3. Effect on thyroid system
Normal human physiology, metabolic control and brain develop-
mental stages are regulated by thyroid hormones. Disruption in thyroid
hormones or delayed release can cause growth, mental and metabolic
disruptions and eventually brain damage [2]. Thyroid system pharma-
cokinetics have been studied as one of the targets for EDC, like PCB,perchlorates, dioxins, BPA, ﬂame retardants, pesticides, polycyclic aro-
matic hydrocarbons (PAHs), and phytoestrogens [39–41]. The EDC can
affect the thyroid system via different ways. EDC can act as an agonist
or antagonist altering the transport or pathways of thyroid hormones
[42]. Organochlorines as potential EDC have been reported to reduce
the level of thyroid hormones, particularly T4 in many species
[43–46]. Other organochlorines like acetochlor and alachlor also cause
a reduction in levels of thyroid hormones (T4) and increase in level of
uridine diphosphate glucuronosyl transferase (UDPGT) [47,48]. Animal
studies proved that PCBs have high afﬁnity to thyroxin speciﬁc binding
proteins, so highly damage normal physiology of thyroid hormones.
This can alter the development, growth and adrenal functions of
human body [49–51]. Exposure to phthalates causes damage in metab-
olism of thyroid hormones in neonates [52]. In rats, histopathological
damages have been detected after exposure to different forms of
phthalates [53–55].
Among other chemicals, parabens are themost commonly used pre-
servatives in the foods. Some relationship has been established for po-
tentiating estrogenic activity of parabens but no animal modeling
studies are available to correlate it to thyroid toxicities [56].
Methylparaben has been evidenced for decreasing thyroid activity and
a dose dependent inhibition of iodide functions was observed during
in vitro studies [57]. So, there is some gap and need to be studied for
parabens to link with thyroid system problems. Pesticides, like DDT
andHCB (hexachlorobenzene) in addition to other EDC have shown de-
velopmental defects in thyroid hormone production. DDT decreases the
thyroid hormones activity while HCB metabolize to give highly toxic
compounds, targeting thyroid hormones [58]. A number of animal stud-
ies are available that support toxic effects of HCB on thyroid hormones
like T3 and T4 [59]. Much more research is pending to ﬁnd out the
link with respect to the thyroid system.
4.4. Obesity and diabetes
Endocrine disruption is amajor cause for obesity, which further links
to diabetes and cardiovascular problems [60]. In hypothesis to explain
obese epidemics, WHO has declared that the total number of obese pa-
tients in the world is now greater than total undernourished patients
[61]. In addition to diabetesmellitus type 2 and cardiac arrest hyperten-
sion, dyslipidemia, insulin resistance and hyperinsulinemia are main
metabolic disorders caused by obesity, which require novel drug ap-
proaches to avoid high mortality rate [62]. In animal modeling studies,
signiﬁcant rise in the weight of mice has been observed, when DES a
pharmaceutical chemical was administered to neonatal mice. In addi-
tion to increase of abdominal body fats, inﬂammatory biomarkers
were also raised in DES exposed animals [63].
Estrogenic receptors (ERα; estrogen receptors alpha) and ERβ (es-
trogen receptors beta) are the key parameters involved in glucose me-
tabolism. Estradiol (E2) and environmental pollutants BPA, dioxins
and pesticides are analogous to each other in targeting these receptors
[64]. The EDC attack such receptors to evoke changes of glucose homeo-
stasis and insulin release mechanism [65]. So any natural or environ-
mental chemical attacking these receptors can damage the normal
physiology of glucose homeostasis and can damage the cells of pancre-
as, giving a clear clue for occurrence of diabetes [66]. A study of Persis-
tent Organic Pollutants (POPs), reveals that a close linkage between
diabetes, obesity and such chemicals does exist in nature. So there are
increased chances of diabetic incidence for human living in such an en-
vironment, having high concentration of environmental pollutants [67].
Epidemiological studies established a link between dioxins like com-
pounds anddiabetes, as different cases of diabetes and glucose homeosta-
sis changes have been reported for susceptible populations in exposure to
dioxins [68]. At very low doses, BPA causes hyperinsulinemia linking to
type 2 diabetes mellitus and obesity [69]. Glucagon is one of the main
hormones produced by α-cells of the pancreas and control glucose me-
tabolism. Even low doses of BPA and DES have been indicated to damage
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dioxins that are slowly released from adipose tissues, after excessive
accumulation disturb glucose homeostasis. Normally they cause
hyperinsulinemia similar to the metabolic state seen during pregnancy.
These hyperestrogenic concentrations ultimately lead to diabetes and
obese condition [71].
4.5. Effect on cardiovascular system
In addition to obesity and diabetes, endocrine disruption also plays a
pivotal role in cardiovascular problems [72]. Animal studies have
proved a link between exposure of DES and cardiovascular problems
[60]. Obesity caused by EDC has been evidenced to induce a number
of coronary heart diseases proceeding toward stroke and blood pressure
problems [73,74]. BPA and phthalates in cross-sectional study have
proved a strong relation to endocrine disruptive mechanisms and car-
diovascular injuries and seem to be involved in destroying both carotid
arteries [75]. Cardiovascular and diabetic problems created by such en-
docrine disruption can lead tometabolic syndromes that can ultimately
increase mortality rate [76,77].
High concentrations of persistent organic polymers have also been
associated with increased rates of coronary heart disease [78–80].
Many man-made and natural substances like plastic bottles, dioxins
like compounds, pesticides and pharmaceuticals are associated with
hormonal imbalances, which are further involved with disturbed state
of cardiac markers physiology [81]. WHO limitations for each compo-
nent for making packagings and other daily used products are needed
to be followed in order to favor human health and reduce cardiac risks.
4.6. Effect on nervous system
Many endocrine disrupting chemicals like herbicides and POP
have an inﬂuence on the nervous system through various receptors,
changing morphology and behavioral response. Some critical devel-
opmental stages like intrauterine, perinatal and puberty periods
have very serious drawbacks as a result of EDC exposure [82]. In an-
imal studies, BPA has shown a close association with schizophrenia
and other neurotoxicological pathology. Neurotoxic problems are as-
sociated with abruptions in different pathways like physical devel-
opment of organs, cellular anatomy, hormone, neurotransmitters
and behavioral response [83]. Estrogen has been thought to have
neuroprotective effects, but lower levels of estrogens may cause
schizophrenia-like symptoms in both males and females [84–87].
Disturbed estrogenic functions may also lead to mutated genetic
makeup. This could further lead to diseases such as Turner's syn-
drome and Klinefelter's syndrome which are contributing toward
schizophrenia [88]. Genetic studies clearly give evidence of psychot-
ic disorders due to Klinefelter's syndrome [89].
Neural disorders have also been linked with hypothalamic–pitui-
tary–adrenal (HPA) axis. Animal studies show the effect of increased
glucocorticoid concentrations on hippocampal nerve damage. In case
of stress, elevated glucocorticoid levels exert change in HPA axis causing
schizophrenia [90]. An altered concentration of corticosterone in animal
studies has also been reported to exert change in theHPA axis, ultimate-
ly raising more chances of schizophrenia [91,92]. EDC directly target
many neuro-steroids like allopregnenolone that regulate mechanism
evoking psychiatric disorders. In addition to this, these steroids also ef-
fect brain regions causing schizophrenia and bipolar disorders. Altered
levels of steroids are directly linked with changing estrogen levels in
the body, but BPA apart from schizophrenia, also seem to be involved
in the other brain disorders like attention deﬁcit hyperactivity disorder
(ADHD) [93,94].
Neural, behavioral and bipolar disorders have also been observed in
infants, children and neonates due to exposure to BPA, that target differ-
ent hormonal pathways [83]. Astrocytes, most often reported target for
BPA, also lead to schizophrenia. Animal modeling studies interlink anincreased concentrations of leukemia inhibitory factor (LIF) with
schizophrenia. Higher level of LIF is involved in decreasingmotor activ-
ity, similar to the abnormal physiology of autoimmune disease
Alzheimer's disease and schizophrenia [95–97]. Likewise, methyl mer-
cury an organic form of mercury has proved increase in oxidative stress
of hippocampus in brain, thus causing neural problems in exposed ani-
mals [98]. Some PCB have shown a damaging effect during develop-
mental stages. Contrary to this, aroclor1221 has shown positive effects
on estrogen receptors in rats during analysis of sexually dimorphic
brain circuits [99]. So, there is a need to critically evaluate different
EDC and their toxicological proﬁles as some may be less harmful for
humans. As other EDC like 2,3,8-tetrachlorodibenzo-p-dioxin (TCDD)
have been reported to possess large effects on brain after administration
in animals. In female rats, damaged myelin layer has been observed
with single dose of 700 ng/kg at 18 gestational days [100–102]. Such ev-
idence urge to domore clinical trials in order to get rid of endocrine tox-
icity related problems.
5. Mechanisms involved in chemicals induced endocrine disruption
EDC effect the normal human physiology in a number of ways. These
may be genomic or non-genomic, via a receptor linked or a non-
receptor linked pathway. The disruptions are caused by a similar mech-
anism as the estrogens and androgens produced naturally in the body,
either through mimicking or opposing actions. Here different mecha-
nisms for endocrine disruptions have been described [103].
5.1. Oxidative stress
It has been recently published that oxidative stress due to reactive
oxygen species and free radical formation is amajor cause for the occur-
rence ofmany diseases [104]. Some evidencehave clearly described that
not only human beings, but also the wildlife is in danger of EDC [105].
Production of reactive oxygen species (ROS) due to endocrine disrup-
tion leads to damaged DNA, protein and lipid production in the cell
(Fig. 2).
EDC: endocrine disrupting chemicals; DES: diethylstilbestrol; BPA:
bisphenol A; PCBs: polychlorinated biphenyls; ROS: reactive oxygen
species; DNA: deoxyribonucleic acid.
5.2. Endocrine disruption by targeting metabolism of steroid hormones
Enzymes involved in the biosynthesis of steroids are ideal targets for
EDC. Damage to normal physiology can cause cancer, reproductive
problems, nervous disorders and growth abnormalities [106]. Cyto-
chrome P450 (CYP450) has a fundamental role in steroid hormone bio-
synthesis regulated by different organs like, adrenal gland, testis, ovary,
brain, placenta and adipose tissues. Organotin compounds widely used
in paint, agriculture and industries have been evidenced to inhibit the
activity of CYP450 and CYP1A1 and aromatase in ﬁsh [107]. All these
lead to endocrine disruptive effects like “imposex (penis development
in females)” by inhibition of aromatase in females [108].
Some derivatives of DDT like DDD (1,1-dichloro-2,2-bis(p-
chlorophenyl)ethane), mitotane; 1-chloro-2-(2,2-dichloro-1-(4-
chlorophenyl)-ethyl)-benzene have been reported to be adrenotoxic
in dogs [109]. It is recently published that benzene is involved in
many non-cancerous health effects like reproductive, immune, nervous,
endocrine, and cardiovascular system problems [110]. In another study
MeSO2-DDE (methylsulfonyl-DDE) has shown adrenotoxic effects
through inhibition of P450c11-mediated functions in adrenocortical
cell lines Y1 and Kin-8 [111]. So toxicity of such daily used chemicals
cannot be avoided, we need to take serious measurements. It has also
been reported that PCB (polychlorinated biphenyls) and many methyl
sulfonated metabolites of PCB inhibit CYP11B1 in Y-1 mouse originated
adrenocortical cells [112]. For clear understanding its mechanism is ex-
plained in Fig. 3.
Fig. 2.Mechanism of action of endocrine disrupting chemicals through production of oxidative stress.
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P-205: protein-205/peroximal proliferator-activated receptor.
5.3. Endocrine disruption by targeting nuclear receptors
Nuclear receptors are actually ligand-inducible transcription factors
that modulate the expression of speciﬁc genes involved in metabolism,
differentiation and sexual functions. More than 100 nuclear receptors
are present, which regulate the response in target cells to hormones
such as sex steroids, adrenal steroids, vitamin D3, thyroid and retinoid
hormones. Natural or synthetic ligands have been known to stimulate
the actions of nuclear receptors called co-activators [113]. Co-
activators include p160 family with intrinsic histone acetyl transferase
activity [114], thyroid hormone receptor activator protein 220, vitamin
D receptor-interacting protein 205/peroximal proliferator-activated re-
ceptor [14] and binding protein lacking intrinsic histone acetyl transfer-
ase activity [115]. An increase in transcriptional activity of nuclear
receptors has been observed in SERM(selective estrogen-receptormod-
ulator) treated cells. Blockage of SRC (steroid receptor co-activator)
family coactivators and CBP (CREB binding protein) has also been evi-
denced in proteasome mediated protein degradation. This happens
due to alteration of gene expressions and inhibition of co-activators ac-
tivity. In SERM treated mouse cells, response to 4HT and raloxifene
shows broad biological actions of ligands, inﬂuencing transcriptional ac-
tivity of nuclear receptors [116].
It has been reported that under the inﬂuence of high fat and high cal-
orie diet, nuclear receptors become activated by organotins that can
stimulate adipocyte differentiation and predisposition progressing to-
ward obesity [117]. Exposure of humans to organotins is mostlyobserved through polluted food sources (seafood and shellﬁsh), fungi-
cides from crops, and contaminated water from textile industries
[118]. Other than organotins, BPA and phthalates have also been evi-
denced for stimulating nuclear hormones and nuclear receptor's linked
pathways resulting in metabolic syndrome [119].
5.4. Endocrine disrupters as hormone sensitizers
Hormones are involved in stimulating and catalyzing a series of bio-
logical reactions in the human body. EDC have been reported to affect
every stage of hormone production cycle [120]. Exposure to xenobiotics
has been observed to cause disturbance in the hormone conduction
pathways. Many chemicals like PCB, dioxins and furans have been evi-
denced to cause thyroid stimulatory actions in the treated animal
while ﬂame retardants cause reduction of thyroid hormone levels in
treated rodents. Phthalates have also been seen to induce the stimulato-
ry actions of TH (thyroid hormones) in opposition to some other
chemicals [40]. In case of short chain fatty acids, valproic acid and
MAA (methoxyacetic acid), by action of EDC, mainly inhibition of his-
tone deacetylases as well as stimulation of the protein kinases have
been observed. Both of these exaggerate hormonal functions and signal-
ing pathways (Fig. 3) [121].
Oral contraceptives and postmenopausal hormone replacement
therapies are main causes of increasing hormonal disturbances. In the
US, it has been reported that among 200 top prescriptions, valproic
acid and EGME/MAA (ethylene glycol monomethyl ether/methoxy
acetic acid) have high EDC properties [122]. MAA (methoxy acetic
acid) administration in rats has shown hormonal disturbingmechanism
like estrogens. They target estrogen receptor beta (ERb) and P450 aro-
matase and thus increases risk of testis cancer [123].
Fig. 3.Mechanism of action of endocrine disrupting chemicals at different hormonal and receptor level.
271F. Maqbool et al. / Life Sciences 145 (2016) 265–2736. Conclusion
It is evident from the above gathered evidence that whole human
physiology has been recognized as a target for EDC. Some risk factors
for endocrine disruptions are seriously fatal for life. Humans as well as
animals are at greater risk of environmental toxicants especially
through inhalational exposure. EDC have damaging effects on central
nervous system, the thyroid system, reproduction, and also have carci-
nogenic effects on different organs and system in the body. Luteinizing
hormones, testosterone, ovarian ﬂuids and some other endocrine hor-
mones are main targets of endocrine disruptions in the reproductive
system as well as carcinogenicity of reproductive organs. Nervous sys-
tem disorders are nominated as amajor target of endocrine disruptions,
particularly targeting hippocampus and hypothalamus of the brain; giv-
ing dangerous outcomes like schizophrenia, and bipolar disorders. EDC
mediate different interruptions in systems and organs via multiple
mechanisms, either targeting steroid hormones or nuclear receptors
which behave as hormone sensitizers. A number of endocrine
disruptors, in routine life, like POP, pesticides, PAH (polyaromatic hy-
drocarbons), VOC (volatile organic compounds), plastic polymers,
food additives, and preservatives have to be studied in more detail, to
ﬁnd a link between different biological systems, disorders and toxicants.
Receptors that are linked to biological pathway disruptions, hormonal
imbalances, and endocrine disruptions are needed to be disclosed. Stud-
ies on EDC compounds illustrate that these can function throughreceptor-mediated and/or non-receptor-mediated pathways to effect
endocrine system. Most complicated and sometimes intermixed mech-
anisms of action of EDC, linkedwith the physical and chemical variation
betweenmembers of the EDC group, propose that, there is possibility of
several additional mechanisms that have yet to be elucidated. In addi-
tion,more progress in thisﬁeldwill dependon the expansion ofmodern
laboratory techniques and experimental models that account for the di-
versity as well as novelty. However, the aim of the study has become so
meaningful and enough to understand the risk factors of endocrine dis-
ruption for the global environment. Apart from these, there is a need to
ﬁnd safe measures to get rid of EDC in daily life.
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